ACTRN12610000502033
Completed
未知
In patients newly diagnosed with breast cancer, will those who receive educational materials about treatment-focused genetic testing experience outcomes (including anxiety, depression, decisional conflict, knowledge of treatment-focused genetic testing, uptake of genetic testing and/or surgery choice) that are no worse than in patients who undergo standard familial cancer centre consultation only.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- early or locally advanced breast cancer
- Sponsor
- Prince of Wales Hospital
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women aged between 18 and \<50 years with early or locally advanced breast cancer will be eligible if they exhibit at least one of the following risk features:
- •1\. A strong family history of breast and/or ovarian cancer, that is There are now (with the new diagnosis) three or more close relatives on one side of the family with breast or ovarian cancer OR There are now (with the new diagnosis) at least two close relatives on one side of the family with breast or ovarian cancer PLUS a high\-risk feature (breast cancer diagnosed before the
- •age of 40, bilateral breast cancer, breast and ovarian cancer in the same woman, Ashkenazi Jewish ancestry, breast cancer in a male relative)
- •2\. No or minimal family history of breast and/or ovarian cancer AND presence of Bilateral breast cancer AND/OR Ashkenazi Jewish ancestry AND/OR Triple negative breast cancer (oestrogen and progesterone receptor and Human Epidermal growth factor Receptor 2 (HER2\) negative tumour)
Exclusion Criteria
- •Women who have already had genetic counselling at a Familial Cancer Clinic (FCC) and/or testing will
- •be excluded. Women with metastatic breast cancer (Stage IV) will also be excluded, as their surgical options will be determined largely by disease characteristics rather than choice.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
In women with breast cancer, does Accelerated Partial Breast Irradiation (APBI) demonstrate acceptable general cosmesis with an improved quality of life?ACTRN12613000551796Dr Yaw Chin.60
Completed
Phase 3
Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up. A Dutch randomized controlled multicentre trial.breast cancersentinel lymph node metastasessentinel lymph nodes1000629110006295NL-OMON54499Medisch Universitair Ziekenhuis Maastricht1,730
Recruiting
Not Applicable
Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up (BOOG 2013-08).breast neoplasmsbreast cancersentinel lymph node biopsybreast conserving therapy.NL-OMON28389KWF, CZ, ZonMw1,644
Completed
Not Applicable
Evaluation of a Pilot Breast Cancer Survivorship Care Plan in New ZealandBreast cancerBreast cancer survivorship care planCancer - BreastACTRN12612001175864Regional Cancer Treatment Service, MidCentral Health DHB30
Active, not recruiting
Phase 1
Pivotal study in breast cancer patients investigating efficacy and safety of LA-EP2006 and Neulasta®Breast CancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-002039-28-ESSandoz GmbH308